Adverse Events following Cancer Immunotherapy: Obstacles and Opportunities

Oncology has recently undergone a revolutionary change with widespread adoption of immunotherapy for many cancers. Immunotherapy using monoclonal antibodies against “checkpoint” molecules, including PD-1, PD-L1, and CTLA-4, is highly effective in a significant subset of patients. However, immune-rel...

Full description

Saved in:
Bibliographic Details
Published in:Trends Immunol
Main Authors: Pauken, Kristen E., Dougan, Michael, Rose, Noel R., Lichtman, Andrew H., Sharpe, Arlene H.
Format: Artigo
Language:Inglês
Published: 2019
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6527345/
https://ncbi.nlm.nih.gov/pubmed/31053497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.it.2019.04.002
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items